title: Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations.
abstract: Edaravone has been reported to have a radioprotective effect at high concentrations. We now report that a lower dose of edaravone enhanced X-ray-induced apoptosis of some cell lines harboring p53 wild-type status, such as MOLT-4, Nalm-6, and HepG2. The knock-down of p53 using siRNA in MOLT-4 cells abolished the radiosensitizing effect of edaravone. Enhanced phosphorylations of p53 at Ser 15 and Ser 20 and up-regulation of PUMA, a p53 target protein, were observed after X-irradiation in the presence of edaravone. We conclude that the low dose of edaravone sensitized cells to X-irradiation by promoting the p53-dependent apoptotic signaling pathway.
authors.affiliation: Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Sasano
authors.forename: A
authors.initials: A
authors.lastname: Enomoto
authors.forename: Y
authors.initials: Y
authors.lastname: Hosoi
authors.forename: Y
authors.initials: Y
authors.lastname: Katsumura
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: A
authors.initials: A
authors.lastname: Morita
authors.forename: K
authors.initials: K
authors.lastname: Shiraishi
authors.forename: K
authors.initials: K
authors.lastname: Miyagawa
authors.forename: H
authors.initials: H
authors.lastname: Igaki
authors.forename: K
authors.initials: K
authors.lastname: Nakagawa
mesh_terms: D000983:Antipyrine / Q000031:analogs & derivatives* / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects* / Q000528:radiation effects; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D000077553:Edaravone; D016166:Free Radical Scavengers / Q000494:pharmacology*; D055785:Gene Knockdown Techniques; D056945:Hep G2 Cells; D006801:Humans; D015458:Leukemia, T-Cell / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D014162:Transfection; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D014965:X-Rays
chemical_list: D016166:Free Radical Scavengers; D011838:Radiation-Sensitizing Agents; D017382:Reactive Oxygen Species; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D000077553:Edaravone; D000983:Antipyrine